|
Oct 4
|
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
|
|
Aug 22
|
Institutional investors own a significant stake of 50% in Compass Therapeutics, Inc. (NASDAQ:CMPX)
|
|
Nov 9
|
Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments
|
|
Nov 9
|
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 7
|
Compass Therapeutics to Participate in Upcoming Investor Events
|